Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1225300
PUBLISHER: IMARC | PRODUCT CODE: 1225300
Central Nervous System (CNS) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global central nervous system (CNS) therapeutics market size reached US$ 131.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 214.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.8% during 2023-2028.
The central nervous system (CNS) represents a vital part of the nervous system that comprises of the brain and the spinal cord. It integrates the received information, thereafter coordinating and controlling the activities of all parts of the body. CNS therapeutics primarily include anesthetics, anticonvulsants, CNS stimulants, muscle relaxants, narcotic analgesics, sedatives, etc. They are widely adopted in the treatment procedures of Parkinson's disease, depression, Alzheimer's disease, epilepsy, traumatic brain, spinal cord injury, CNS cancer, etc.
Central Nervous System (CNS) Therapeutics Market Trends:
- The elevating prevalence of mental illness and lifestyle-associated CNS disorders, including anxiety, depression, hypertension, etc., is primarily driving the global CNS therapeutics market. In line with this, the growing geriatric population, who are more prone to chronic neurological ailments such as Alzheimer's disease and Parkinson's disease, is also propelling the global market. Additionally, the emerging popularity of generic neurologic drugs across developing countries on account of their affordability is further augmenting the market for CNS therapeutics. Apart from this, continuous innovations in CNS treatment procedures, such as the development of gene therapy, neurostimulation tools, and neural transplantation techniques, are also stimulating the market growth. These approaches prolong the action of unremitting dopaminergic stimulation medicines and control disease progression. Moreover, the introduction of novel drug-delivery systems that provide ease of administration and availability of different dosage forms is further creating a positive outlook for the global CNS market. For instance, transdermal patches are gaining traction in the field of neurology to treat CNS disorders as they offer a precise amount of medicine and relief for around 24 hours. Besides this, the increasing focus of the government and non-government organizations on creating awareness regarding numerous CNS disorders and the accessibility to multiple treatment options is also catalyzing the market growth. Moreover, the launch of favorable guidelines to support faster approvals of pipeline drugs for neurodegenerative diseases and clinical trials that encourage the entry of new products is expected to drive the global central nervous system therapeutics market in the coming years.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global central nervous system (CNS) therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disease and application.
Breakup by Disease:
- Neurodegenerative Diseases
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Huntington's Disease
- Amyotrophic Lateral Sclerosis
- Others
- Neurovascular Diseases
- CNS Trauma
- Mental Health
- Anxiety Disorders
- Epilepsy
- Mood Disorders
- Psychotic Disorders
- Others
- Infectious Diseases
- CNS Cancer
- Others
Breakup by Application:
- Hospital
- Clinic
- Homecare
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca plc, Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding), H. Lundbeck A/S, Merck & Co. Inc., Neurocrine Biosciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
- Key Questions Answered in This Report
- 1. What was the size of the global Central Nervous System (CNS) therapeutics market in 2022?
- 2. What is the expected growth rate of the global Central Nervous System (CNS) therapeutics market during 2023-2028
- 3. What are the key factors driving the global Central Nervous System (CNS) therapeutics market?
- 4. What has been the impact of COVID-19 on the global Central Nervous System (CNS) therapeutics market?
- 5. What is the breakup of the global Central Nervous System (CNS) therapeutics market based on the disease?
- 6. What are the key regions in the global Central Nervous System (CNS) therapeutics market?
- 7. Who are the key players/companies in the global Central Nervous System (CNS) therapeutics market?
Product Code: SR1423A141_Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Central Nervous System (CNS) Therapeutics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Disease
- 6.1 Neurodegenerative Diseases
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Alzheimer's Disease
- 6.1.2.2 Parkinson's Disease
- 6.1.2.3 Multiple Sclerosis
- 6.1.2.4 Huntington's Disease
- 6.1.2.5 Amyotrophic Lateral Sclerosis
- 6.1.2.6 Others
- 6.1.3 Market Forecast
- 6.2 Neurovascular Diseases
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 CNS Trauma
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Mental Health
- 6.4.1 Market Trends
- 6.4.2 Key Segments
- 6.4.2.1 Anxiety Disorders
- 6.4.2.2 Epilepsy
- 6.4.2.3 Mood Disorders
- 6.4.2.4 Psychotic Disorders
- 6.4.2.5 Others
- 6.4.3 Market Forecast
- 6.5 Infectious Diseases
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 CNS Cancer
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Others
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
7 Market Breakup by Application
- 7.1 Hospital
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Clinic
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Homecare
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 AstraZeneca plc
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Biogen Inc.
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Eli Lilly and Company
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 F. Hoffmann-La Roche AG (Roche Holding)
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 SWOT Analysis
- 13.3.5 H. Lundbeck A/S
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.5.4 SWOT Analysis
- 13.3.6 Merck & Co. Inc.
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.6.4 SWOT Analysis
- 13.3.7 Neurocrine Biosciences Inc.
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Novartis AG
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.9 Pfizer Inc.
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.9.4 SWOT Analysis
- 13.3.10 Sanofi S.A.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.10.4 SWOT Analysis
- 13.3.11 Takeda Pharmaceutical Company Limited
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.11.3 Financials
- 13.3.11.4 SWOT Analysis
- 13.3.12 Teva Pharmaceutical Industries Ltd.
- 13.3.12.1 Company Overview
- 13.3.12.2 Product Portfolio
- 13.3.12.3 Financials
- 13.3.12.4 SWOT Analysis
- 13.3.1 AstraZeneca plc
Product Code: SR1423A141_Report
List of Figures
- Figure 1: Global: Central Nervous System Therapeutics Market: Major Drivers and Challenges
- Figure 2: Global: Central Nervous System Therapeutics Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Central Nervous System Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Central Nervous System Therapeutics Market: Breakup by Disease (in %), 2022
- Figure 5: Global: Central Nervous System Therapeutics Market: Breakup by Application (in %), 2022
- Figure 6: Global: Central Nervous System Therapeutics Market: Breakup by Region (in %), 2022
- Figure 7: Global: Central Nervous System Therapeutics (Neurodegenerative Diseases) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 8: Global: Central Nervous System Therapeutics (Neurodegenerative Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 9: Global: Central Nervous System Therapeutics (Neurovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Central Nervous System Therapeutics (Neurovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Central Nervous System Therapeutics (CNS Trauma) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Central Nervous System Therapeutics (CNS Trauma) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Central Nervous System Therapeutics (Mental Health) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Central Nervous System Therapeutics (Mental Health) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Central Nervous System Therapeutics (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Central Nervous System Therapeutics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Central Nervous System Therapeutics (CNS Cancer) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Central Nervous System Therapeutics (CNS Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Central Nervous System Therapeutics (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Central Nervous System Therapeutics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Central Nervous System Therapeutics (Hospital) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Central Nervous System Therapeutics (Hospital) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Central Nervous System Therapeutics (Clinic) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Central Nervous System Therapeutics (Clinic) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Central Nervous System Therapeutics (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Central Nervous System Therapeutics (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Central Nervous System Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Central Nervous System Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: North America: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: North America: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: United States: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: United States: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: Canada: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: Canada: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Asia-Pacific: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Asia-Pacific: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: China: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: China: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: Japan: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: Japan: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: India: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: India: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: South Korea: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: South Korea: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: Australia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: Australia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: Indonesia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: Indonesia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: Europe: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: Europe: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: Germany: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: Germany: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: France: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: France: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: United Kingdom: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: United Kingdom: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: Italy: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: Italy: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: Spain: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: Spain: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Russia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Russia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: Latin America: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: Latin America: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Brazil: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Brazil: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Mexico: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Mexico: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Middle East and Africa: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Middle East and Africa: Central Nervous System Therapeutics Market: Breakup by Country (in %), 2022
- Figure 77: Middle East and Africa: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 78: Global: Central Nervous System Therapeutics Industry: SWOT Analysis
- Figure 79: Global: Central Nervous System Therapeutics Industry: Value Chain Analysis
- Figure 80: Global: Central Nervous System Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Central Nervous System Therapeutics Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Disease (in Million US$), 2023-2028
- Table 3: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 4: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 5: Global: Central Nervous System Therapeutics Market: Competitive Structure
- Table 6: Global: Central Nervous System Therapeutics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.